Chinese patent medicine Xuefu Zhuyu capsule for the treatment of unstable angina pectoris: A systematic review of randomized controlled trials

Complementary Therapies in Medicine

Volumn 22, Issue 2, 2014, Pages 391-399

  Yang, Xiaochen ^a   Xiong, Xingjiang ^a   Yang, Guoyan ^b   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Bu Wen Ding Xin jiao tong (unstable angina pectoris); Guan xin bing (coronary heart disease); Xuefu Zhuyu

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHINESE DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG; XUEFU ZHUYU; HERBACEOUS AGENT; XUE-FU-ZHU-YU DECOCTION;

CHINESE MEDICINE; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; HEADACHE; HUMAN; META ANALYSIS; MORTALITY; NAUSEA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM; SYSTEMATIC REVIEW; UNSTABLE ANGINA PECTORIS; ADULT; AGED; ANGINA, UNSTABLE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; DRUGS, CHINESE HERBAL; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898811379     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.01.003     Document Type: Review

References (42)

1. Bernard R., Corday E., Eliasch H., Gonin A., et al. Nomenclature and criteria for diagnosis of ischemic heart disease, the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979, 59:607-609.
2. Braunwald E., Morrow D.A. Unstable angina: is it time for a requiem?. Circulation 2013, 127:2452-2457.
3. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e5-e92.
4. Pollack C.V., Braunwald E. 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 2007, 51(5):591-606.
5. Wiviott S.D., Braunwald E. Unstable angina and non-ST-segment elevation myocardial infarction: part I. Initial evaluation and management, and hospital care. Ann Emerg Med 2004, 70(3):525-532.
6. Zavecz J.H., Bueno O. Pharmacologic therapy of angina pectoris. J La State Med Soc 1995, 147(5):208-210. 213-6.
7. Taggart D. Tailor treatment to the patient instable angina. Practitioner 2011, 255(1744):25-28.
8. Chen K.J., Xu H. The integration of traditional Chinese medicine and Western medicine Institute for clinical systems improvement. Eur Rev 2003, 11(2):225-235.
9. Tindle H.A., Davis R.B., Phillips R.S., Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alternat Ther Health Med 2005, 11(1):42-49.
10. Eisenberg D. Reflections on the past and future of integrative medicine from a lifelong student of the integration of Chinese and western medicine. Chin J Integr Med 2011, 17(1):3-5.
11. Jun S., Chen W.Y., Chen K.J., et al. A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction on endothelial cells. Chin J Intergr Med 2012, 18(7):502-506.
12. Zhang Q.Y., Wang Q.L., Su J.F., et al. Angiogenesis effects of Xuefu Zhuyu Decoction and VEGF protein expression of rats with acute myocardial ischemia. Chin J Info TCM 2011, 18(2):53-54.
13. Cui H.J., He H.Y., Xing Z.H. Systematic review and meta-analysis of Xuefu Zhuyu Decoction in patients with unstable angina. J Emerg Trad Chin Med 2011, 20(7):1071-1075.
14. Zheng G.H., Chu J.F., Liu J.P. Systematic review of Xuefu Zhuyu Capsule for angina pectoris in patients with coronary heart disease. J Trad Chin Med 2012, 53(2):117-122.
15. Song X.M. Meta-analysis of Xuefu Zhuyu Decoction combined with asprin and isosorbide mononitrate for angina pectoris in patients with coronary heart disease. J Pract Med 2010, 26(14):2633-2636.
16. Wang C.L.Q.W., Wang S.L. Meta-analysis of modefied Xuefu Zhuyu Decoction in patients with coronary heart disease. J Liaoning Univ TCM 2011, 13(11):5-9.
17. American College of Cardiology and American Heart Association ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. Circulation 2000, 102:1193-1209.
18. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease Report of the joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979, 3:607-609.
19. Ministry of health of the People's Republic of China Clinical research guidelines for new traditional Chinese drug, August 1993, 42-44.
20. Higgins JPT, Green S. Cochrane Reviewers' Handbook 5.1.0 [updated March 2011]. Review Manager (RevMan) [Computer program]. Version 5.1.0.
21. Qiu W.D., Yang C.Y. Clinical observation of Xuefu Zhuyu Decoction for unstable angina and effect of Hs-CRP in patients with coronary heart disease. Clin J Chin Med 2012, 4(6):14-15.
22. Zhang Z.X., Song X.P. Clinical observation of modified Xuefu Zhuyu Decoction for unstable angina in 50 cases. Hebei J Trad Chin Med 2006, 28(4):275-276.
23. Wang F.Q. Clinical observation of modified Xuefu Zhuyu Decoction for unstable angina in patients with coronary heart disease. J Changchun Univ Trad Chin Med 2011, 27(1):87-88.
24. Zhao B.R., Feng J.P., Qin Q., et al. Protective Effect of Xuefu Zhuyu Capsule for endothelial cells due to angina pectoris in patients with coronary heart disease. Nat Gen Med J China 2002, 3(9):791-792.
25. Li Y.R., Zhang H.F., Du J., et al. Clinical observation of Xuefu Zhuyu Capsule for unstable angina in patients with coronary heart disease. J Liaoning Univ Trad Chin Med 2008, 10(11):103-104.
26. Chu F.Y., Wang J., Yao K.W., et al. Effect of Xuefu Zhuyu Capsule on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: a randomized controlled trial. Chin J Integr Med 2010, 16(5):399-406.
27. Wang X.Y., Lou Y. Combination of Xuefu Zhuyu Decoction with western medicine for unstable angina in 56 cases with coronary heart disease. Tianjin J Trad Chin Med 2008, 26(6):521.
28. Zheng G.L., Wang S.H. Clinical effect and mechanism of Xuefu Zhuyu Capsule in treating unstable angina pectoris. Chin J Integr Trad West Med 2009, 29(1):65-69.
29. Wang Q., Wu T., Chen X., et al. Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 2006, 19(3):CD004196.
30. Andraws R., Berger J.S., Brown D.L. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. Cochrane Database Syst Rev 2005, 293(21):2641-2647.
31. Zhang J.H., Shang H.C., Gao X.M., et al. Compound salvia droplet pill, a traditional Chinese medicine, for the treatment of unstable angina pectoris: a systematic review. Med Sci Monit 2008, 14(1):1-7.
32. Wu T., Harrison R.A., Chen X., et al. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst Rev 2006, 18(4):CD004474.
33. Wang J., Yang X., Chu F., et al. The effects of Xuefu Zhuyu and Shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial. Evid Based Complement Alternat Med 2013, 2013:896467. 10.1155/2013/896467.
34. Wang J., Yang X., Feng B., et al. Is yangxue qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension?. Evid Based Complement Alternat Med 2013, 2013:540613. 10.1155/2013/540613.
35. Wang J., Yao K., Yang X., et al. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2012, 714805. 10.1155/2012/714805.
36. Food and Drug Administration of the People's Republic of China Guidelines for clinical research in treatment of Qi stagnation of chest with Chinese medicine (Angina pectoris) - Guidelines for Clinical Research with Chinese Medicine/New Medicine 2002, 68-73. China Medical Science and Technology Press.
37. Hu J., Zhang J.H., Zhao W., et al. Cochrane systematic reviews of Chinese herbal medicines: an overview. PLoS One 2011, 6:1371.
38. Turner L., Shamseer L., Altman D.G., et al. Does use of the CONSORT statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 2012, 1(60). 10.1186/2046-4053-1-60.
39. Turner L., Shamseer L., Altman D.G., et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012, 14(11). 10.1002/14651858.
40. Xiong X.J., Yang X.C., Liu W., Feng B., Ma J.Z., Du X.L., et al. Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2012, 2012:10. [Article ID 271462]. 10.1155/2012/271462.
41. Xiong X.J., Yang X.C., Feng B., Liu W., Duan L., Gao A., et al. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2013, 2013:9. [Article ID 982380].
42. Smith S.M., Chang R.D., Pereira A., et al. Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review. Pain 2012, 153(12):2415-2421.